TITLE 845 BOARD OF PODIATRIC MEDICINE
Notice of Intent to Adopt a Rule
LSA Document #15-416
Under
IC 4-22-2-23, the Board of Podiatric Medicine intends to adopt a rule concerning the following:
OVERVIEW: Adds
845 IAC 2 to establish standards and protocols for the prescribing of controlled substances by podiatrists, consistent with standard medical practices in pain management treatment, including the use of abuse deterrent formulations. Public comments are invited and may be directed to the Indiana Board of Podiatric Medicine: Darren R. Covington, J.D., Director, 402 West Washington Street, Room W072, Indianapolis, Indiana 46204 or by e-mail to dcovington@pla.in.gov. Statutory authority:
IC 25-22.5-13-3;
IC 25-29.
For purposes of
IC 4-22-2-28.1, the Small Business Regulatory Coordinator for this rule is:
Darren R. Covington, J.D.
Indiana Professional Licensing Agency
Indiana Government Center South
402 West Washington Street, Room W072
Indianapolis, IN 46204
(317) 234-2011
dcovington@pla.in.gov
Erik Scheub
Office of Small Business and Entrepreneurship
One North Capitol, Suite 600
Indianapolis, IN 46204
(317) 232-5679
ombudsman@osbe.in.gov
Resources available to regulated entities through the small business ombudsman include the ombudsman's duties stated in
IC 4-4-35-8, specifically
IC 4-4-35-8(9), investigating and attempting to resolve any matter regarding compliance by a small business with a law, rule, or policy administered by a state agency, either as a party to a proceeding or as a mediator.
Posted: 11/25/2015 by Legislative Services Agency
DIN: 20151125-IR-845150416NIA
Composed: Apr 25,2024 12:44:28PM EDT
A
PDF version of this document.